Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
FDF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
ABOUT THIS PAGE
A Voxilaprevir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Voxilaprevir, including repackagers and relabelers. The FDA regulates Voxilaprevir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Voxilaprevir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Voxilaprevir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Voxilaprevir supplier is an individual or a company that provides Voxilaprevir active pharmaceutical ingredient (API) or Voxilaprevir finished formulations upon request. The Voxilaprevir suppliers may include Voxilaprevir API manufacturers, exporters, distributors and traders.
click here to find a list of Voxilaprevir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Voxilaprevir Drug Master File in Korea (Voxilaprevir KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Voxilaprevir. The MFDS reviews the Voxilaprevir KDMF as part of the drug registration process and uses the information provided in the Voxilaprevir KDMF to evaluate the safety and efficacy of the drug.
After submitting a Voxilaprevir KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Voxilaprevir API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Voxilaprevir suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Voxilaprevir as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Voxilaprevir API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Voxilaprevir as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Voxilaprevir and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Voxilaprevir NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Voxilaprevir suppliers with NDC on PharmaCompass.
Voxilaprevir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Voxilaprevir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Voxilaprevir GMP manufacturer or Voxilaprevir GMP API supplier for your needs.
A Voxilaprevir CoA (Certificate of Analysis) is a formal document that attests to Voxilaprevir's compliance with Voxilaprevir specifications and serves as a tool for batch-level quality control.
Voxilaprevir CoA mostly includes findings from lab analyses of a specific batch. For each Voxilaprevir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Voxilaprevir may be tested according to a variety of international standards, such as European Pharmacopoeia (Voxilaprevir EP), Voxilaprevir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Voxilaprevir USP).
LOOKING FOR A SUPPLIER?
